Investing

First Look Analysts Research Calls for Thursday, March 23

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Accolade (ACCD) upgraded to Buy from Neutral at Guggenheim; tgt $16

> Americold Realty Trust (COLD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $32

> ArcelorMittal (MT) upgraded to Buy from Neutral at BofA Securities

> BellRing Brands (BRBR) upgraded to Buy from Hold at Truist; tgt raised to $40

> Inozyme Pharma (INZY) upgraded to Buy from Hold at Jefferies; tgt raised to $6

> Marathon Oil (MRO) upgraded to Buy from Neutral at Citigroup; tgt $27

> ORIC Pharmaceuticals (ORIC) upgraded to Buy from Neutral at H.C. Wainwright; tgt $16

> Pioneer Natural Resources (PXD) upgraded to Buy from Neutral at Citigroup; tgt raised to $210

> Regency Centers (REG) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $70

Downgrades:

> Amwell (AMWL) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $2.50

> Boston Properties (BXP) downgraded to Equal Weight from Overweight at Barclays; tgt $57

> Chewy (CHWY) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $35

> Coinbase Global (COIN) downgraded to Perform from Outperform at Oppenheimer

> M&T Bank (MTB) downgraded to Peer Perform from Outperform at Wolfe Research

> nCino (NCNO) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets

> Ovintiv (OVV) downgraded to Neutral from Buy at Citigroup; tgt lowered to $38

> Samsara (IOT) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $19

> SL Green Realty (SLG) downgraded to Underweight from Equal Weight at Barclays; tgt $22

Others:

> AMC Entertainment (AMC) resumed with a Sell at Citigroup; tgt $1.60

> Disc Medicine (IRON) initiated with an Outperform at BMO Capital Markets; tgt $40

> Dynatrace (DT) initiated with a Buy at Stifel; tgt $45

> HashiCorp (HCP) initiated with a Buy at BTIG Research; tgt $37

> IDEAYA Biosciences (IDYA) initiated with a Buy at Berenberg; tgt $26

> Intuitive Surgical (ISRG) initiated with an Outperform at William Blair

> Mobileye Global (MBLY) initiated with a Hold at WestPark Capital

> NVIDIA (NVDA) initiated with a Hold at WestPark Capital

> Qualcomm (QCOM) initiated with a Hold at WestPark Capital

> Roper (ROP) initiated with a Neutral at Mizuho; tgt $475

> Select Energy Services (WTTR) initiated with a Strong Buy at Raymond James; tgt $12

> Sociedad Quimica y Minera (SQM) initiated with an Outperform at Bradesco BBI

> Talos Energy (TALO) initiated with an Overweight at KeyBanc Capital Markets; tgt $18

> Western Alliance Bancorp (WAL) initiated with an Outperform at Hovde Group

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.